XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 556 shares, an increase of 561.9% from the May 31st total of 84 shares. Based on an average trading volume of 1,420 shares, the days-to-cover ratio is presently 0.4 days.
XOMA Price Performance
XOMAP opened at $25.48 on Friday. The company’s 50 day simple moving average is $25.51 and its 200 day simple moving average is $26.03. XOMA has a 1 year low of $25.14 and a 1 year high of $30.00.
XOMA Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 14th. Shareholders of record on Thursday, July 2nd will be paid a dividend of $0.5391 per share. The ex-dividend date of this dividend is Thursday, July 2nd. This represents a $2.16 dividend on an annualized basis and a yield of 8.5%.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
- Five stocks we like better than XOMA
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
- MarketBeat Week in Review – 06/22 – 06/26
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
